Article Details

BridgeBio Pharma Hauls in $299M for Genetic Disease Drugs R&D

Retrieved on: 2019-01-22 23:11:15

Tags for this article:

Click the tags to see associated articles and topics

BridgeBio Pharma Hauls in $299M for Genetic Disease Drugs R&D. View article details on hiswai:

Excerpt

<div>Xconomy San Francisco —. Biotech startup creator BridgeBio Pharma has raised $299.2 million to support its work developing new drugs to treat rare, ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up